Abstract
The advent of next generation sequencing (NGS) has dramatically impacted the practice of hematopathology and the role of the clinical laboratory in information management and reporting. While the ability to simultaneously interrogate multiple gene loci for copy number, single nucleotide and large structural variations from one platform affords detailed examination of the genomes of hematologic malignancies, the integration of pre-analytical and technical workflows in genomic diagnostics and bioinformatics to ensure a seamless transmission of clinically relevant information offers opportunities for enhancement. In this session, a review of the parameters to be considered encompassing target selection, assay design, validation and performance specification test implementation will be covered. Considerations for options for reporting of clinical laboratory results to clinicians and oncologists to facilitate delivery of precision medicine will be examined. Disclosures Elenitoba-Johnson: Genomenon: Equity Ownership.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.